Electrical Pharyngeal Stimulation for Dysphagia Therapy in Tracheostomized Stroke Patients

Sponsor
University Hospital Muenster (Other)
Overall Status
Completed
CT.gov ID
NCT01956175
Collaborator
(none)
30
1
2
18
1.7

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate whether electrical pharyngeal stimulation in addition to standard care can enhance short-term swallow recovery in tracheostomized dysphagic stroke patients and thereby facilitate earlier decannulation compared to sham treatment plus standard care.

Condition or Disease Intervention/Treatment Phase
  • Device: Electrical pharyngeal stimulation
  • Device: Sham stimulation
N/A

Detailed Description

Readiness for decannulation is assessed after three days of either real or sham electrical pharyngeal stimulation. In case a patient cannot be decannulated at that time point, there is an open-label follow-up treatment phase, in which every patient in the sham treatment arm gets another three days of real electrical pharyngeal stimulation to not deprive any patient of a potentially beneficial treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Single-centre, Double Blind, Randomised Controlled Clinical Trial to Evaluate the Effect of Electrical Pharyngeal Stimulation as a Treatment for Stroke-related Dysphagia in Tracheostomized Stroke Patients
Study Start Date :
Jun 1, 2013
Actual Primary Completion Date :
Aug 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Electrical pharyngeal stimulation

Electrical pharyngeal stimulation once daily for 10 minutes on three consecutive days.

Device: Electrical pharyngeal stimulation
Electrical pharyngeal stimulation via an intraluminal catheter (Phagenesis Ltd.) once daily for 10 minutes on three consecutive days. The intensity of the electrical stimulation is determined following the calculation of suitable sensory threshold, tailored to the individual participants. After determining the optimal stimulation intensity, 10 minutes of stimulation are delivered.
Other Names:
  • Phagenesis Limited, UK.
  • EPS1 device
  • Sham Comparator: Sham stimulation

    Sham stimulation once daily for 10 minutes on three consecutive days. If the subject cannot be decannulated after three days of sham stimulation, another three days of real electrical pharyngeal stimulation will be delivered.

    Device: Sham stimulation
    The intraluminal catheter (Phagenesis Ltd.) for electrical pharyngeal stimulation is placed. The intensity of the electrical stimulation is determined following the calculation of suitable sensory threshold, tailored to the individual participants. After the optimal stimulation intensity has been determined, no electrical stimulation is delivered.

    Outcome Measures

    Primary Outcome Measures

    1. Readiness for decannulation [3 days]

      Difference in readiness for decannulation as assessed by a standardized fiberoptic endoscopic evaluation protocol after three days of treatment between real and sham treatment groups

    Secondary Outcome Measures

    1. Functional Oral Intake Scale (FOIS) at discharge [until discharge]

    2. modified Rankin Scale (mRS) at discharge [until discharge]

    3. length of stay on ICU / in the hospital and time from stimulation to discharge [until discharge]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • severe dysphagia due to acute stroke

    • completely weaned from mechanical ventilation

    • impossibility of decannulation because of severe dysphagia with ongoing aspiration

    Exclusion Criteria:
    • preexisting dysphagia

    • comorbidities that can possibly cause dysphagia

    • psychiatric comorbidities

    • pacemaker or other implanted electronic devices

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Neurology, University of Muenster Muenster Germany 48129

    Sponsors and Collaborators

    • University Hospital Muenster

    Investigators

    • Principal Investigator: Rainer Dziewas, PhD, Department of Neurology, University of Muenster

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital Muenster
    ClinicalTrials.gov Identifier:
    NCT01956175
    Other Study ID Numbers:
    • 2011-580
    First Posted:
    Oct 8, 2013
    Last Update Posted:
    Feb 20, 2015
    Last Verified:
    Feb 1, 2015
    Keywords provided by University Hospital Muenster
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 20, 2015